Research Topics
| Yun Shin ChunSummaryAffiliation: Fox Chase Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Significance of pathologic response to preoperative therapy in pancreatic cancerYun Shin Chun
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Ann Surg Oncol 18:3601-7. 2011..Pathologic response to preoperative therapy is increasingly recognized as an important prognostic factor in solid tumors. The impact of pathologic response on survival in pancreatic adenocarcinoma is not well established...- Defining venous involvement in borderline resectable pancreatic cancerYun Shin Chun
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Ann Surg Oncol 17:2832-8. 2010..There is no consensus about what degree of venous impingement constitutes borderline resectability... - Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastasesYun Shin Chun
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA
JAMA 302:2338-44. 2009.... - Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetryYoji Kishi
Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
Ann Surg 250:540-8. 2009..Secondary end point was to assess whether preoperative portal vein embolization (PVE) is associated with improved outcome in patients with initial sFLR ≤ 20%... - Is embolization of segment 4 portal veins before extended right hepatectomy justified?Yoji Kishi
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
Surgery 144:744-51. 2008..However, whether segment 4 (S4) portal veins should be embolized is controversial. The effect of S4 PVE on the volume gain of segments 2 and 3 (S2+3) was examined... - Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapyYoji Kishi
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Ann Surg Oncol 16:614-22. 2009..Whether neutrophil-to-lymphocyte ratio (NLR) predicts survival of patients with colorectal liver metastases (CLM) treated with systemic chemotherapy remains unclear... - Fibrolamellar variant of hepatocellular carcinomaYun Shin Chun
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Recent Results Cancer Res 190:101-10. 2013..Despite complete surgical resection, relapse rates are high, and novel therapies are needed to prevent and treat recurrent disease... - Management of chemotherapy-associated hepatotoxicity in colorectal liver metastasesYun Shin Chun
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Lancet Oncol 10:278-86. 2009.... - Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastasesDan G Blazer
Department of Surgical Oncology, Gastrointestinal Medical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
J Clin Oncol 26:5344-51. 2008..The secondary goal of the study was to identify the clinical predictors of pathologic response... 
The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric arteryPavlos Papavasiliou
Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Int J Surg Oncol 2012:538769. 2012..009). Conclusion. The first jejunal branch of the SMV has a highly variable course in relation to the SMA and has a higher incidence of an anterior location in this population than previously reported...